Disorders of the Pancreas

Published on 06/06/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2016 times

114 Disorders of the Pancreas

Disorders of the pancreas (Figure 114-1) are rare in childhood but can be associated with significant morbidity and mortality. Pancreatitis occurs less frequently in children than in adults and can be either acute or chronic in nature. It can be complicated by shock, hypocalcemia, pseudocyst formation, or necrosis, but these complications are rare. Pancreatic insufficiency (PI), defined as insufficient lipase secretion resulting in fat malabsorption, affects about 80% to 90% of patients with cystic fibrosis (CF). Congenital anomalies of the pancreas, such as pancreas divisum and annular pancreas, are found in approximately 10% of the general population and are generally asymptomatic but can be associated with pancreatitis (pancreas divisum) or duodenal obstruction (annular pancreas).

Etiology and Pathogenesis

Pancreatitis

The frequency of pancreatitis (i.e., inflammation of the pancreas) in children and adolescents has been increasing over the past 10 to 15 years. There are several common causes of pancreatitis, including blunt abdominal trauma; infections such as enterovirus, Epstein-Barr virus, hepatitis A, rubella, Coxsackie virus B, cytomegalovirus, HIV, and influenza; congenital anomalies of the pancreas; choledochal cysts; and choledocholithiasis. Medications, including azathioprine, 6-mercaptopurine, glucocorticoids, valproate, and L-asparaginase, can cause pancreatitis. Pancreatitis can also be the result of systemic diseases and metabolic abnormalities, including CF, diabetic ketoacidosis, hypercalcemia, hyperlipidemia, and hemolytic-uremic syndrome.

Pancreatitis occurs when intracellular trypsinogen and other digestive enzymes are activated, leading to damage of the pancreatic acinar cells. This damage leads to pancreatic edema (Figure 114-2), a local inflammatory response, and the initiation of autodigestion of the pancreas. These pancreatic secretions may form a collection that becomes walled off by granulation tissue to form a pseudocyst.

Chronic pancreatitis occurs with recurrent episodes of acute pancreatitis, leading to chronic inflammation as well as end-stage fibrosis (see Figure 114-2). The most common causes of chronic pancreatitis in children are CF, hereditary pancreatitis including mutations in the SPINK1, CFTR, and PRSS1 genes, and idiopathic causes.

Cystic Fibrosis

Pancreatic insufficiency in patients with CF is caused by dysfunction of the CFTR gene (Figure 114-3). This leads to impaired transport of sodium and chloride and subsequent obstruction of the pancreatic ducts with viscous exocrine fluid. These patients have diminished secretion of amylase, lipase, colipase, and phospholipases, as well as a decreased concentration of bicarbonate in their pancreatic secretions.

Clinical Presentation

Evaluation and Management

Pancreatitis

A thorough history is important to distinguish pancreatitis from other causes of acute abdominal pain. It is important to determine the onset and the character of the pain, as well as any other associated symptoms. A complete list of current medications is important to obtain because many medications may cause pancreatitis, including nonsteroidal antiinflammatory drugs, corticosteroids, antibiotics (sulfonamides, tetracyclines), diuretics (thiazides, furosemide), azathioprine, and mercaptopurine, to name a few. The laboratory evaluation should include amylase and lipase levels, which may be elevated more than three times the upper limit of normal but can be unreliable because they may be elevated for reasons other than pancreatitis (Table 114-1). An ultrasound may reveal an enlarged pancreas with an alteration in echogenicity and can also identify the presence of a pseudocyst. Other findings on ultrasound may include gallstones or biliary sludge in the case of gallstone pancreatitis, pancreatic calcifications, choledochal cysts, dilated pancreatic ducts, or dilated common or hepatic bile ducts. Magnetic resonance cholangiopancreatography can be helpful in further identifying ductal abnormalities. In patients with recurrent or chronic pancreatitis, genetic testing for SPINK1, CF, and cationic trypsinogen (PRSS1) can be helpful. Additionally, an elevated triglyceride level may indicate hyperlipidemia as a cause of recurrent pancreatitis.

Table 114-1 Causes of Elevated Amylase and Lipase Levels

Amylase Lipase

ERCP, endoscopic retrograde cholangiopancreatography.

Treatment of children with pancreatitis is generally supportive and includes pancreatic and bowel rest with nothing per mouth, intravenous (IV) fluids, gastric acid blockade, and pain management. Nevertheless, physicians should remain vigilant for signs of severe complications such as shock, peritonitis, or hypocalcemia. Amylase and lipase values may be followed, although treatment decisions should be based primarily on the patient’s clinical status and symptoms. In patients who cannot tolerate oral intake for more than 48 hours, nasojejunal feeding can be used to safely provide nutrition as an alternative to IV hyperalimentation. In the approximately 13% of patients who develop a pseudocyst, drainage may be required if it does not resolve spontaneously. Cholecystectomy is indicated in patients with gallstone pancreatitis or biliary sludge. An endoscopic retrograde cholangiopancreatography (ERCP) may be required if there is evidence of acute biliary or pancreatic duct obstruction or in cases of recurrent pancreatitis in which there is concern for a ductal or structural abnormality. Pancreatic necrosis occurs in fewer than 1% of children with pancreatitis and may require surgical intervention for pancreatic debridement or necrosectomy. A number of surgical procedures are also available for patients with chronic pancreatitis.